
Sign up to save your podcasts
Or


In the third and final episode of our miniseries on infectious disease diagnostics, Jonathan sits down with global diagnostics leader Rosanna Peeling, Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine. Together, they explore the life-saving role of diagnostics in global health, from battling STDs to confronting COVID-19, and examine how equitable access, social innovation, and regulatory reform can transform disease control and pandemic preparedness.
Timestamps:
00:00 – Introduction
06:09 – Rosanna's interest in microbiology
08:12 – The IDC's work
10:52 – Funding for diagnostics
13:30 – Diagnostic testing in low-resource settings
18:21 – Chlamydia research
24:19 – Regulatory approval challenges
29:35 – Social innovation
34:08 – Clinician adaptation
37:10 – Current diagnostic innovations
40:30 – Rosana's three wishes for healthcare
Rafael Fonseca is a distinguished Haematologist at Mayo Clinic, specialising in multiple myeloma and related plasma cell disorders. He earned his medical degree at Universidad Anáhuac in Mexico, and went on to complete his residency in Internal Medicine at the University of Miami, Florida, USA followed by a Hematology and Oncology fellowship at Mayo Clinic in Rochester, Minnesota, USA.
Timestamps
01:44 – Quickfire questions
07:25 – CAR-T cell therapy
10:48 – Anti-CD38 antibodies
13:31 – Minimal residual disease
14:30 – Bispecific antibodies
15:31 – Antibody-drug conjugates
19:04 – ASCO 2025
21:24 – Genetic discoveries
26:28 – Fonseca's three wishes
In this episode, Jonathan Sackier kicks off a special miniseries on lung cancer with Haval Balata, Consultant Respiratory Physician at Manchester University NHS Foundation Trust. From the Manchester Lung Health Check to robotic bronchoscopy, Balata shares insights into pioneering early detection efforts, the challenge of public misconceptions, and innovations reshaping lung cancer screening and diagnosis.
Timestamps:
03:12 – Inspiration to specialise 04:09 – Early diagnosis barriers 08:02 – Manchester Lung Health Check 14:10 – Robot-assisted bronchoscopy 19:24 – Public misconceptions 28:57 – Risk stratification & follow-up 34:24 – Innovations in early detection 37:10 – Hopes for the future 41:22 – Three healthcare wishes
In this two-part series host Jonathan Sackier is joined by Bradley Monk, a pioneering figure in gynaecologic oncology. In Part 1, they discuss key updates from the European Society of Gynaecological Oncology (ESGO) Congress, including the updated ESGO-ESTRO-ESP endometrial cancer guidelines and the latest results from the KEYLYNK-001 study in ovarian cancer. With reflections from his three-decade career, Monk provides actionable takeaways for clinicians and researchers alike. Stay tuned for Part 2, where they delve into insights from SGO 2025.
Timestamps:
00:00 - Quickfire questions 04:55 - Career milestones 07:10 - ESGO 2025 standout sessions 09:52 - KEYLYNK-001 trial & takeaways 13:52 - New endometrial cancer staging
In this bonus episode, join EMJ host Dr Hannah Moir as she speaks with our two urological experts, Dr Todd Linsenmeyer and Dr Chris Harding. They discuss recent advances in day-to-day technologies for intermittent catheterisation, covering innovations and advancements in catheter technology aimed at improving the user experience.
In this three-part series, Jonathan Sackier sits down with Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA. Together, they discuss the importance of hope in patient care and the inspiration behind starting her own practice.
Timestamps:
1:12 – A typical consultation
7:50 – Advice for clinicians
In this three-part series, Jonathan Sackier sits down with Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA. Together, they discuss the importance of hope in patient care and the inspiration behind starting her own practice.
Timestamps:
0:14 – The power of hope for patients 1:08 – Opening her own practice
In this three-part series, Jonathan Sackier sits down with Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA. Together, they discuss the importance of hope in patient care and the inspiration behind starting her own practice.
Timestamp:
2:27 – The origins of 'Hope Driven by Science'
In this episode of Hema Now, host Jonathan Sackier is joined by Paolo Gallipoli, Clinical Reader at the Centre for Haemato-Oncology at Barts Cancer Institute, to break down the biology, onset, and treatment of myeloid leukaemias. They detail common misconceptions about myeloid leukaemias, explain the differences between chronic myeloid leukaemia and acute myeloid leukaemia, and discuss Gallipoli's own research in the field, with a view towards future developments.
Timestamps
01:34 – Quickfire questions
06:55 – Potential careers
08:43 – Common misconceptions
11:34 – Best advice received
13:43 – Adaptive metabolic changes
16:45 – Chronic myeloid leukaemia vs acute myeloid leukaemia
19:20 – Recent publication
22:55 – Clonal hematopoiesis
27:13 – Treatment obstacles
29:18 – Future developments
31:01 – Gallipoli's three wishes
In this three-part series, Jonathan Sackier sits down with Richard Conway, rheumatologist, researcher, and educator. Together, they delve into cutting-edge insights on polymyalgia rheumatica, immune ageing, and the future of rheumatology care.
01:47 – Interstitial Lung Disease
08:25 – Evolution of Rheumatology
11:39 – Wishes for Healthcare
From the publisher's feed

40 Listeners